Three Steps to Cure Pulmonary Fibrosis. Step 1: The Runaway Train or Groundhog Day?

por Jenkins, R. Gisli
Publicado 2020

Beyond epithelial damage: vascular and endothelial contributions to idiopathic pulmonary fibrosis

por May, James, Mitchell, Jane A., Jenkins, R. Gisli
Publicado 2023

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy

por George, Peter M, Wells, Athol U, Jenkins, R Gisli
Publicado 2020

COVID-19 in Patients with Chronic Lung Disease

por Calver, Jessica Fae, Fabbri, Laura, May, James, Jenkins, R. Gisli
Publicado 2023

A systematic review of blood biomarkers with individual participant data meta-analysis of matrix metalloproteinase-7 in idiopathic pulmonary fibrosis

por Khan, Fasihul A., Stewart, Iain, Saini, Gauri, Robinson, Karen A., Jenkins, R. Gisli
Publicado 2022

Shared genetic risk factors: implications for treatment of idiopathic pulmonary fibrosis and systemic hypertension

por Parcesepe, Gina, Allen, Richard J., Guillen-Guio, Beatriz, Moss, Samuel, Jenkins, R. Gisli, Wain, Louise V.
Publicado 2023

Genetic overlap between idiopathic pulmonary fibrosis and COVID−19

por Allen, Richard J, Guillen-Guio, Beatriz, Croot, Emma, Kraven, Luke M, Moss, Samuel, Stewart, Iain, Jenkins, R Gisli, Wain, Louise V
Publicado 2022

Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity

por Fadista, João, Kraven, Luke M., Karjalainen, Juha, Andrews, Shea J., Geller, Frank, Baillie, J Kenneth, Wain, Louise V., Jenkins, R.Gisli, Feenstra, Bjarke
Publicado 2021

Stretch regulates alveologenesis and homeostasis via mesenchymal G(αq/11)-mediated TGFβ2 activation

por Goodwin, Amanda T., John, Alison E., Joseph, Chitra, Habgood, Anthony, Tatler, Amanda L., Susztak, Katalin, Palmer, Matthew, Offermanns, Stefan, Henderson, Neil C., Jenkins, R. Gisli
Publicado 2023

Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK®trial

por Maher, Toby M, Stowasser, Susanne, Nishioka, Yasuhiko, White, Eric S, Cottin, Vincent, Noth, Imre, Selman, Moisés, Blahova, Zuzana, Wachtlin, Daniel, Diefenbach, Claudia, Jenkins, R Gisli
Publicado 2018

Safety and tolerability of nintedanib in patients with progressive fibrosing interstitial lung diseases: data from the randomized controlled INBUILD trial

por Cottin, Vincent, Martinez, Fernando J., Jenkins, R. Gisli, Belperio, John A., Kitamura, Hideya, Molina-Molina, Maria, Tschoepe, Inga, Coeck, Carl, Lievens, Dirk, Costabel, Ulrich
Publicado 2022

The Use of Genetic Information to Define Idiopathic Pulmonary Fibrosis in UK Biobank

por Leavy, Olivia C., Allen, Richard J., Kraven, Luke M., Morgan, Ann D., Tobin, Martin D., Quint, Jennifer K., Jenkins, R. Gisli, Wain, Louise V.
Publicado 2023

Adjustment for index event bias in genome-wide association studies of subsequent events

por Dudbridge, Frank, Allen, Richard J., Sheehan, Nuala A., Schmidt, A. Floriaan, Lee, James C., Jenkins, R. Gisli, Wain, Louise V., Hingorani, Aroon D., Patel, Riyaz S.
Publicado 2019

Mapping brain endophenotypes associated with idiopathic pulmonary fibrosis genetic risk

por Mohammadi-Nejad, Ali-Reza, Allen, Richard J., Kraven, Luke M., Leavy, Olivia C., Jenkins, R. Gisli, Wain, Louise V., Auer, Dorothee P., Sotiropoulos, Stamatios N.
Publicado 2022

The IL-33:ST2 axis is unlikely to play a central fibrogenic role in idiopathic pulmonary fibrosis

por Stephenson, Katherine E., Porte, Joanne, Kelly, Aoife, Wallace, William A., Huntington, Catherine E., Overed-Sayer, Catherine L., Cohen, E. Suzanne, Jenkins, R. Gisli, John, Alison E.
Publicado 2023

Reply to Althuwaybi et al.: Hospitalization Outcomes for COVID-19 in Patients with Interstitial Lung Disease: A Potential Role for Aerodigestive Pathophysiology?

por Chaudhuri, Nazia, George, Peter M., Kreuter, Michael, Molina-Molina, Maria, Rivera-Ortega, Pilar, Stella, Giulia M., Stewart, Iain, Spencer, Lisa G., Wells, Athol U., Jenkins, R. Gisli
Publicado 2021

Proportion of Idiopathic Pulmonary Fibrosis Risk Explained by Known Common Genetic Loci in European Populations

por Leavy, Olivia C., Ma, Shwu-Fan, Molyneaux, Philip L., Maher, Toby M., Oldham, Justin M., Flores, Carlos, Noth, Imre, Jenkins, R. Gisli, Dudbridge, Frank, Wain, Louise V., Allen, Richard J.
Publicado 2021

Novel idiopathic pulmonary fibrosis susceptibility variants revealed by deep sequencing

por Lorenzo-Salazar, Jose M., Ma, Shwu-Fan, Jou, Jonathan, Hou, Pei-Chi, Guillen-Guio, Beatriz, Allen, Richard J., Jenkins, R. Gisli, Wain, Louise V., Oldham, Justin M., Noth, Imre, Flores, Carlos
Publicado 2019

Genetically increased circulating FUT3 level leads to reduced risk of idiopathic pulmonary fibrosis: a Mendelian randomisation study

por Nakanishi, Tomoko, Cerani, Agustin, Forgetta, Vincenzo, Zhou, Sirui, Allen, Richard J., Leavy, Olivia C., Koido, Masaru, Assayag, Deborah, Jenkins, R. Gisli, Wain, Louise V., Yang, Ivana V., Lathrop, G. Mark, Wolters, Paul J., Schwartz, David A., Richards, J. Brent
Publicado 2022

Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation

por Singh, Sally J, Baldwin, Molly M, Daynes, Enya, Evans, Rachael A, Greening, Neil J, Jenkins, R Gisli, Lone, Nazir I, McAuley, Hamish, Mehta, Puja, Newman, Joseph, Novotny, Petr, Smith, David J F, Stanel, Stefan, Toshner, Mark, Brightling, Christopher E
Publicado 2023